Ellis, Ian O.
Nottingham University Hospitals NHS Trust,
United Kingdom
2025 Rank: 40682
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 1205 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 40682 | 43551 |
| Total Cites | 4559 | 4900 |
| H-index | 26 | 26 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 18 | 21 |
| Number of Single+First+Last Authored Papers | 275 | 275 |
| Total Cites to Single+First+Last Authored Papers | 804 | 866 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3676 | 3818 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.28 |
| Self-Citation Percentage |
6.96%
|
|
Ellis, Ian O.
University of Nottingham,
United Kingdom
2024 Rank: 31190
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 991 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 31190 | 34382 |
| Total Cites | 4705 | 5049 |
| H-index | 25 | 26 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 20 | 21 |
| Number of Single+First+Last Authored Papers | 273 | 273 |
| Total Cites to Single+First+Last Authored Papers | 886 | 952 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3754 | 3894 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.30 |
| Self-Citation Percentage |
6.81%
|
|
Ellis, Ian O.
Nottingham University Hospitals NHS Trust,
United Kingdom
2023 Rank: 17301
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 626 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 17301 | 19440 |
| Total Cites | 5373 | 5806 |
| H-index | 28 | 28 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 38 | 40 |
| Number of Single+First+Last Authored Papers | 269 | 269 |
| Total Cites to Single+First+Last Authored Papers | 1154 | 1222 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4050 | 4240 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.37 |
| Self-Citation Percentage |
7.46%
|
|
Ellis, Ian O.
University of Nottingham Medical School,
United Kingdom
2022 Rank: 19317
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 723 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 19317 | 20874 |
| Total Cites | 4942 | 5404 |
| H-index | 27 | 28 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 28 | 31 |
| Number of Single+First+Last Authored Papers | 265 | 265 |
| Total Cites to Single+First+Last Authored Papers | 984 | 1039 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3928 | 4096 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.32 |
| Self-Citation Percentage |
8.55%
|
|
Ellis, Ian O.
University of Nottingham,
United Kingdom
2021 Rank: 16540
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 607 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 16540 | 17698 |
| Total Cites | 7219 | 7987 |
| H-index | 32 | 34 |
| Hm-index | 12 | 13 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 8 | 8 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 47 | 47 |
| Number of Single+First+Last Authored Papers | 260 | 260 |
| Total Cites to Single+First+Last Authored Papers | 1589 | 1697 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5640 | 5927 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.35 |
| Self-Citation Percentage |
9.62%
|
|
Ellis, Ian O.
University of Nottingham,
United Kingdom
2020 Rank: 12753
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 458 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 12753 | 13724 |
| Total Cites | 5050 | 5575 |
| H-index | 27 | 29 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 15 | 15 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 42 | 42 |
| Number of Single+First+Last Authored Papers | 260 | 260 |
| Total Cites to Single+First+Last Authored Papers | 1224 | 1306 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3964 | 4197 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.33 |
| Self-Citation Percentage |
9.42%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.